Autism spectrum disorder (ASD) is a heterogeneous neuropsychiatric condition affecting an
estimated one in 36 children. Youth with ASD may have severe behavioral disturbances …

Autism spectrum disorder (ASD) is a heterogeneous neuropsychiatric condition that, based
on recent CDC estimates affects an estimated 1 in 59 American children. Behavioral …

Autism spectrum disorder (ASD) is characterized by impairment in social communication
and restricted patterns of behavior. Although there is no pharmacological treatment …

Current evidence-based pharmacotherapy options in children with ASD are very limited, and
many have substantial adverse events. Clinicians should use pharmacotherapy as a part of …

Autism and other pervasive developmental disorders (PDDs) are frequently associated with
dysfunctional behaviors and are characterized by deficits in socialization, communication …

This chapter will focus on the pharmacologic treatment of adolescents (12–18 years) and
adults with autism spectrum disorders (ASDs). Research on the pharmacotherapy of …

Autism spectrum disorders (ASDs) are a complex group of neurodevelopmental conditions
that develop in early childhood and involve a range of impairments in core areas of social …

Pharmacological Therapies for Autism Spectrum Disorder: A Review - PMC Back to Top
Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage …

To date, no medication is proven to be effective in treating core symptoms of autism
spectrum disorder (ASD). Psychotropic medications are widely used to target emotional and …

Ei: 33EEEEEEEEE"| EEEEEEEEEE| n recent years increasingly rigorous pharmacotherapy
study has addressed interfering symptoms asso-ciated with autism and related pervasive …